Related references
Note: Only part of the references are listed.Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism
Kazuhide Hayakawa et al.
JOURNAL OF NEUROCHEMISTRY (2007)
HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
Jung-Bin Kim et al.
JOURNAL OF NEUROSCIENCE (2006)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness - Functional inactivation of rage in L6 myoblasts results in tumor formation in vivo
F Riuzzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Evidence for novel cannabinoid receptors
M Begg et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Amphoterin as an extracellular regulator of cell motility: from discovery to disease
HJ Huttunen et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Cannabidiol prevents infarction via the non-CBI cannabinoid receptor mechanism
K Hayakawa et al.
NEUROREPORT (2004)
Cutting edge: HMG-1 as a mediator of acute lung inflammation
E Abraham et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
